Otsuka, a top pharmaceutical company, is reviewed in terms of partnering, licensing and M&A interests and activity over recent years Read the full story

Lundbeck and Otsuka , both amongst the top 50 big biotech companies, announced a license and development biopharma partners agreement Read the full story

Otsuka Pharmaceutical and H. Lundbeck, both being  big pharma companies, outlined co-promotion plans and summarized the overall progress in their pharma partnering at a session in Japan with representatives from domestic and international media organizations Read the full story

India based injectables player, Claris Lifesciences is in talks with Japenese based pharma giant, Ostuka Pharma, to sell its injectibles business in what is anticipated to be a M&A agreement. Read the full story

Turkey's pharma market isn't as high-profile as the oft-celebrated China or India. But that doesn't mean big pharma aren't looking for ways to beef up their operations in the country. As one of the world's "pharmerging" markets, according to IMS Health, its growth prospects certainly outstrip the moribund Europe and sluggish U.S. And it's also becoming a production hub.

Read the full story

Following a pharma partners agreement, Catalent has commenced supply to big pharma, Otsuka Pharmaceutical of Abilify OD Tablets which utilize Catalent’s Zydis fast dissolve drug delivery technology.

Read the full story

In a pharma business deal, Proteus Digital Health and Otsuka Pharmaceutical have entered into an exclusive worldwide license and collaboration agreement to develop and commercialize a new category of medicines.

Read the full story

In Otsuka Pharmaceutical Co. v. Sandoz, Inc., the Federal Circuit upheld the district court's determination that the claims at issue were neither obvious nor invalid under the doctrine of obviousness-type double patenting based on a "lead compound" approach to the obviousness determinations Read the full story

This report provides all the information you require to better understand Otsuka and its partnering interests and activities over the past seven years. Read the full story

In one of the largest partnering deals of the year, Lundbeck and Otsuka have entered into a long-term agreement for the development and commercialization of up to five innovative psychiatric and neuroscience products worldwide Read the full story